PUBLICATIONS

Сlinical trials in the Czech Republic – Country Profile 2021 Cromos Pharma began working in the Czecя Republic (Czechia) in the 2010s and established a representative office in Prague in 2015. The country has a strong track record in clinical research delivering high quality data. In recent years, it has moved towards becoming a location for more niche clinical trials including those focused on cell Read more

Rare disease clinical trials factsheet It is estimated that 475 million people worldwide are affected by a rare disease. Drug development for rare diseases involves significant challenges above and beyond those encountered in large trials for more common diseases. Partnering with Cromos Pharma means working with an international CRO with a strong track record in innovative trial design, exceptional multi-country Read more

Conducting Clinical Trials in Poland – Country Profile 2021 Poland is the largest clinical trials market in central and Eastern Europe. Cromos Pharma has been managing clinical research in Poland since 2015 and opened a permanent office in Warsaw in February 2020. WHY POLAND? Strong track record over 20 years of producing high quality data. Large population (38.5 million) in comparison with neighboring countries Read more

Clinical trial of RPH-104 in acute ST-Elevation Myocardial Infarction: Design and Rationale Read the article in the Journal of Translational Medicine co-authored by Dr Vlad Bogin about the study design and its rationale here Cromos Pharma proudly supports the Right2hope nonprofit platform, empowering patients to explore treatment options beyond traditional clinical trials. Through an intuitive, AI-supported matching algorithm, Right2hope connects patients with the most relevant expanded access, Read more